The orthoferrite YFeO3 with orthorhombic perovskite structure (Pnma) has been synthesized by mild hydrothermal method. The temperature-dependent magnetization and hysteresis loops indicate that, due to the superexchange and Dzyaloshinskii-Moriya interactions in the crystals, the Fe spins order antiferromagnetically at the Néel temperature 655 K with a weak ferromagnetic moment. The observation of saturation polarization loops at room temperature and 77 K provide evidence for the ferroelectric character of the polycrystalline samples. Its Curie temperature has been obtained from the temperature dependence of the relative permittivities and thermal analysis. As a result, the structure exhibits simultaneously weak ferromagnetic and ferroelectric behavior.
In this work, a green chemistry strategy was developed to synthesize blue pigments SrCuSi4O10 and BaCuSi4O10 with good yield and high purity. SrCuSi4O10 and BaCuSi4O10 exhibit hierarchical structures. Our study shows that hydrothermally synthesized BaCuSi2O6 exhibits interesting broad near-infrared luminescence.
The phase‐pure AgNbO3 has been prepared through the hydrothermal reactions of NH4HF2, Ag2O, and Nb2O5. The room‐temperature powder X‐ray diffraction analysis reveals that it crystallizes in orthorhombic perovskite lattice with a space group of Pmc21 and cell parameters a = 15.6999(9), b = 5.5521(1), and c = 5.5830(1) Å. The temperatures, pH values, and times play crucial roles in obtaining phase‐pure silver niobate. The structural phase transitions were observed at 813 K from cubic to tetrahedral phase and to final orthorhombic phase at 718 K, confirmed by TGA‐DTA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.